SAGE Therapeutics Appoints James M. Frates To The Company’s Board Of Directors
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced the appointment of James M. Frates to the company’s board of directors.
Help employers find you! Check out all the jobs and post your resume.